| [1] | Yikai WANG, Fengping WU, Chenrui LIU, Miao HAO, Shasha LYU, Miaomiao ZHANG, Shuangsuo DANG, Xin ZHANG. Dynamic change and significance of Mindin protein in chronic hepatitis B treated with PEG-IFNα-2b[J]. Journal of Clinical Hepatology, 2024, 40(1): 52-57. doi: 10.12449/JCH240110 |
| [2] | Kuan LI, Huibin NING, Huiming JIN, Zhen PENG, Jia SHANG. Effect of pegylated interferon α-2b on serum HBsAg clearance rate in treatment of patients with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2023, 39(8): 1819-1824. doi: 10.3969/j.issn.1001-5256.2023.08.009 |
| [3] | Yan HUANG, Qiongyue ZHANG, Erping LUO, Weifeng ZHAO, Jianhe GAN. Clinical cure of the non-dominant population in chronic hepatitis B patients with HBsAg>3000 IU/mL: A report of two cases[J]. Journal of Clinical Hepatology, 2022, 38(7): 1608-1611. doi: 10.3969/j.issn.1001-5256.2022.07.027 |
| [4] | Chen Xi, Zhao WenJing, Sun Yan, Yin HaiYan. Value of baseline HBsAg quantification in predicting the clinical effect of pegylated interferon α-2b in treatment of chronic hepatitis B[J]. Journal of Clinical Hepatology, 2020, 36(8): 1723-1726. doi: 10.3969/j.issn.1001-5256.2020.08.009 |
| [5] | Ji WeiJia, Yan XueBing. Clinical effect and safety of pegylated interferon-α-2a versus pegylated interferon-α-2b in treatment of chronic hepatitis B [J]. Journal of Clinical Hepatology, 2019, 35(2): 309-314. doi: 10.3969/j.issn.1001-5256.2019.02.013 |
| [6] | Guo ChunXia, Li Jia, Xu CengLi, Guo Jie, Zhai Lu, Han Xu. Impact of HBV DNA detection methods on evaluating the clinical effect of PEG-IFNɑ-2b in treatment of HBeAg-positive chronic hepatitis B: a comparative analysis[J]. Journal of Clinical Hepatology, 2017, 33(4): 664-667. doi: 10.3969/j.issn.1001-5256.2017.04.013 |
| [7] | Ai ZhengLin, Xie BuShan, Yao ShuKun. Clinical effect of matrine in treatment of rats with nonalcoholic steatohepatitis[J]. Journal of Clinical Hepatology, 2016, 32(11): 2163-2166. doi: 10.3969/j.issn.1001-5256.2016.11.033 |
| [8] | Liu YuanYuan, Guo XiaoLin, Jin JingLan. One case of nephrotic syndrome complicated by decompensated hepatitis C cirrhosis treated with hormone and interferon[J]. Journal of Clinical Hepatology, 2014, 30(1): 72-73. doi: 10.3969/j.issn.1001-5256.2014.01.020 |
| [9] | Zhao XiaoLing, Zhang YongGang. Clinical efficacy of ribavirin combined with different doses of interferon α- 2b in patients with chronic hepatitis C genotypes 2 and 3[J]. Journal of Clinical Hepatology, 2013, 29(10): 780-783. doi: 10.3969/j.issn.1001-5256.2013.10.014 |
| [10] | Yan ShuangHuan, Cao ZhiChen. Changes in Toll-like receptor 4 expression on the surface of peripheral blood monocytes in patients with chronic hepatitis B during interferon treatment [J]. Journal of Clinical Hepatology, 2012, 28(11): 828-830. |
| [11] | Zhao WenLi, Cheng Hong, Yang ZhongMin. Effects of combination therapy of matrine with adefovir dipivoxil on hepatic fibrosis in patients with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2011, 27(5): 490-492. |
| [12] | Shi QingFeng, Song JiKui, Zhang YingXin, Yuan JianGuo, Wang SiKui, Li QingFang, Zhao HongKui. Study on the expression of HLA-DR/CD69 on CD4+/CD8+T cells in the treatment of HBeAg-positive chronic hepatitis B with interferon alfa-2b[J]. Journal of Clinical Hepatology, 2011, 27(12): 1285-1287+1300. |
| [13] | Jin Rui, Zhang ShiBin, Bian XinQu, Lu ChengZhen, Liu ZhongSheng, Guo XinHui. Clinical study of IFNα-2b alone or in combination with lamivudine for HBeAg positive chronic hepatitis B[J]. Journal of Clinical Hepatology, 2011, 27(6): 617-619. |
| [14] | Li YunHua, Yang LuHua, Liu TongGang, Li Zhi. Protective effect of matrine on chemotherapy in HBVM-positive pulmonary tuberculosis patients [J]. Journal of Clinical Hepatology, 2010, 26(5): 522-523. |
| [16] | Cui Kun, Fan GongRen, Chen TianBao, Ji ShengJie, Hou BaoQuan, Gong XinHui, Li YiZhuo, Gao Hui, Qin Meng. Clinical Observation on chronic hepatitis B With low ALT Theated by interferon and yexiazhu[J]. Journal of Clinical Hepatology, 2008, 24(5): 343-345. |
| [17] | Xiao Yang, Hu CaoHan, Zhou YueJin, Xie QingRong, Zhu BingXing, Hu Xia, Wang KaiJian, Zhang WenJing. Effect of hepatitis B virus genotypes on response to interferon α2b in the treatment of chronic hepatitis B[J]. Journal of Clinical Hepatology, 2006, 22(2): 105-106. |
| [19] | Chang RongLin, Liu YiQun, Zhang ZhaoRu, Chen Hong. Clinical observation on treatment of chronic hepatitis B with combination of matrine and diammonium glycyrrhizinate.[J]. Journal of Clinical Hepatology, 2004, 20(3): 165-166. |
DownLoad: